心房細動の日本人患者におけるワルファリン治療の大出血合併症の頻度

SUZUKI Shinya; YAMASHITA Takeshi; KATO Takeshi; FUJINO Tadashi; SAGARA Koichi; SAWADA Hitoshi; AIZAWA Tadanori; FU Long-tai

文献

J-GLOBAL ID：200902223011467092 整理番号：07A0434228

心房細動の日本人患者におけるワルファリン治療の大出血合併症の頻度

Incidence of Major Bleeding Complication of Warfarin Therapy in Japanese Patients With Atrial Fibrillation

出版者サイト {{ this.onShowPLink() }} 複写サービスで全文入手
高度な検索・分析はJDreamⅢで {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=07A0434228&from=J-GLOBAL&jstjournalNo=F0908A") }}

著者 (8件)： , , , , , , ,
資料名：
巻： 71 号： 5 ページ： 761-765 (J-STAGE) 発行年： 2007年
JST資料番号： F0908A ISSN： 1346-9843 資料種別：逐次刊行物 (A)
記事区分：原著論文発行国：日本 (JPN) 言語：英語 (EN)

背景:非弁膜性心房細動(NVAF)の患者で卒中を防止するため...

,...

続きはJDreamIII（有料）にて {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=07A0434228&from=J-GLOBAL&jstjournalNo=F0908A") }}

循環系疾患の薬物療法

引用文献 (21件)：

1. Inoue H, Nozawa T, Hirai T, Iwasa A, Okumura K, Lee JD, et al. Accumulation of risk factors increases risk of thromboembolic events in patients with nonvalvular atrial fibrillation. Circ J 2006; 70: 651-656.
2. Okishige K, Fukunami M, Kumagai K, Atarashi H, Inoue H, Pilsicainide Suppression Trial for Persistent Atrial Fibrillation II Investigators. Pharmacological conversion of persistent atrial fibrillation into sinus rhythm with oral pilsicainide: Pilsicainide suppression trial for persistent atrial fibrillation II. Circ J 2006; 70: 657-661.
3. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990; 323: 1505-1511.
4. Ezekowitz MD, Bridgers SL, James KE, Carliner NH, Colling CL, Gornick CC, et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation: Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. N Engl J Med 1992; 327: 1406-1412.
5. Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: The Copenhagen AFASAK study. Lancet 1989; 333: 175-179.

, , , , , , ,

前のページに戻る